Your browser doesn't support javascript.
loading
Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide database.
Ishikawa, Yuichi; Tokutsu, Kei; Nakayamada, Shingo; Kuchiba, Aya; Fushimi, Kiyohide; Matsuda, Shinya; Tanaka, Yoshiya.
Afiliación
  • Ishikawa Y; The First Department of Internal Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
  • Tokutsu K; Graduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Japan.
  • Nakayamada S; Sato Clinic, Shibuya-ku, Japan.
  • Kuchiba A; Preventive Medicine and Community Health, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
  • Fushimi K; The First Department of Internal Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
  • Matsuda S; Graduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Japan.
  • Tanaka Y; Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Bunkyo-ku, Japan.
Ann Rheum Dis ; 83(1): 103-111, 2024 Jan 02.
Article en En | MEDLINE | ID: mdl-37726117

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía por Pneumocystis / Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos / Enfermedades Renales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía por Pneumocystis / Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos / Enfermedades Renales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2024 Tipo del documento: Article País de afiliación: Japón